WHO's role in the global health system: What can be learned from global R&D debates?

Public Health

Volumn 128, Issue 2, 2014, Pages 167-172

  Moon, Suerie ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Access to medicines; Antibiotics; Consultative Expert Working Group on R D (CEWG); Intellectual property; Neglected diseases; Pharmaceuticals; R D treaty; Research and development; WHO reform; World Health Organization

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTICS; HEALTH CARE; INTELLECTUAL PROPERTY RIGHTS; MEDICINE; RESEARCH AND DEVELOPMENT; WORLD HEALTH ORGANIZATION;

ACCESS TO INFORMATION; DRUG USE; GLOBAL RESEARCH AND DEVELOPMENT SYSTEM; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; MONITORING; POLITICAL SYSTEM; PUBLIC-PRIVATE PARTNERSHIP; PUBLICATION; REVIEW; WORLD HEALTH ORGANIZATION;

ACCESS TO MEDICINES; ANTIBIOTICS; CONSULTATIVE EXPERT WORKING GROUP ON R&D (CEWG); INTELLECTUAL PROPERTY; NEGLECTED DISEASES; PHARMACEUTICALS; R&D TREATY; RESEARCH AND DEVELOPMENT; WHO REFORM; WORLD HEALTH ORGANIZATION;

DISSENT AND DISPUTES; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTERNATIONAL COOPERATION; POVERTY; PROFESSIONAL ROLE; RESEARCH; WORLD HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84892786150     PISSN: 00333506     EISSN: 14765616     Source Type: Journal    
DOI: 10.1016/j.puhe.2013.08.014     Document Type: Review

References (25)

1. Research and development to meet health needs in developing countries: strengthening global financing and coordination 2012, WHO Consultative Expert Working Group on Research and Development (CEWG): Financing and Coordination, World Health Organization, Geneva, [Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination].
2. Rottingen J., Moon S., Tangcharoensathien V., Hoffman S.J. Multi-stakeholder technical meeting on implementation options recommended by the WHO Consultative Expert Working Group on Research & Development (CEWG): Financing and Coordination 2012, International Health Policy Program-Thailand and the Harvard Global Health Institute, Cambridge, MA.
3. Moon S., Bermudez J., 't Hoen E. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?. PLoS Med 2012, 9:e1001218.
4. Potet J., Athersuch K. Stuck in a time warp: WHO-brokered global R&D action plan shelved 2012, Speaking of Medicine PLoS Medicine Community Blog.
5. Moon S., Rottingen J. Demonstrating progress: building a more equitable global R&D system 2013, PLoS Medicine Community Blog.
6. Hermann R.M. World health assembly: as members approve health R&D decisions, US says time to "put our money where our mouth is" 2013, Intellectual Property Watch (IP Watch).
7. Clift C. The role of the World Health Organization in the international system 2013, Chatham House, London, [Center on Global Health Security Working Group Papers].
8. IHME Financing global health 2012: the end of the golden age? 2012, Institute for Health Metrics and Evaluation (IHME), Seattle.
9. Frenk J., Moon S. Governance challenges in global health. N Engl J Med 2013, 368:936-942.
10. World Health Organization (WHO) Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits 2011, WHO, Geneva.
11. World Health Assembly (WHA) Global strategy and plan of action on public health, innovation and intellectual property 2008, Resolution 61.21.
12. Bloom B. WHO needs change. Nature 2011, 473:143-145.
13. Fidler D. Architecture amidst anarchy: Global Health's quest for governance. Glob Health Gov 2007, 1.
14. Lamy P., Chan M., Gurry F. Opening remarks: creating synergies between intellectual property rights and public health 2010.
15. Helfer L.R. Regime shifting in the international intellectual property system. Perspect Polit 2009, 7:39.
16. Constitution of the World Health Organization 2006, World Health Assembly (WHA), Basic documents. 45th edn. Supplement, October 2006.
17. Moon S., Omole O. Development assistance for health: critiques and proposals for change 2013, Working Group on Finance, paper 1, Chatham House, London, [Global Health Security Working Papers].
18. The WTO in brief: the organization 2013, World Trade Organization (WTO), Accessed 4/8, 2013, at:. http://www.wto.org/english/thewto_e/whatis_e/inbrief_e/inbr02_e.htm.
19. Love J.P. KEI proposal: a WTO agreement on the supply of knowledge as a global public good 2008, Knowledge Ecology International, Washington DC.
20. Sell S.K. The global IP upward ratchet, anti-counterfeiting and piracy enforcement efforts: the state of play 2008, IQ Sensato occasional paper #1, IQ Sensato, Geneva.
21. Polgreen L. Group of emerging nations plans to form development bank 2013, The New York Times.
22. Chan M. WHO Director-General launches joint report on public health, intellectual property, and trade. Remarks at the launch of the joint WHO/WIPO/WTO report on promoting access to medical technologies and innovation 2013, Speeches of the Director General.
23. Chan M. New business models for medical innovation (opening remarks at a joint WHO/WIPO/WTO technical symposium on medical innovation: changing business models, 5 July 2013) 2013.
24. Moon S. Can (MICs) governments make the global R&D system work for all? 2013, Global Health Governance Blog.
25. Hoffman S.J., Røttingen J. Assessing implementation mechanisms for an international agreement on research and development for health products. Bull World Health Organ 2012, 90:854-863.